BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20500494)

  • 21. Imiquimod 5% cream in the treatment of Bowen's disease.
    Mackenzie-Wood A; Kossard S; de Launey J; Wilkinson B; Owens ML
    J Am Acad Dermatol; 2001 Mar; 44(3):462-70. PubMed ID: 11209116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study.
    Martin-García RF; Busquets AC
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1394-8. PubMed ID: 16416606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of PCR to estimate the prevalence of Equus caballus papillomavirus in aural plaques in horses.
    Gorino AC; Oliveira-Filho JP; Taniwaki SA; Basso RM; Zakia LS; Araujo JP; Borges AS
    Vet J; 2013 Sep; 197(3):903-4. PubMed ID: 23773810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
    Gill VL; Bergman PJ; Baer KE; Craft D; Leung C
    Vet Comp Oncol; 2008 Mar; 6(1):55-64. PubMed ID: 19178663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety studies of topical imiquimod 5% cream on normal skin exposed to ultraviolet radiation.
    Kaidbey K; Owens M; Liberda M; Smith M
    Toxicology; 2002 Sep; 178(2):175-82. PubMed ID: 12160622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aural plaques in two imported horses in New Zealand.
    Fairley RA; Morley CM; Williams SD; Senior DA; Neill MA
    N Z Vet J; 2014 Jul; 62(4):232-3. PubMed ID: 24245824
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
    Barba AR; Kapoor S; Berman B
    Dermatol Online J; 2001 Feb; 7(1):20. PubMed ID: 11328641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical treatment of nasal squamous papilloma with imiquimod cream.
    Caversaccio M; Aebi S
    J Laryngol Otol; 2003 Sep; 117(9):720-2. PubMed ID: 14561362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute renal failure caused by imiquimod 5% cream in a renal transplant patient: review of the literature on side effects of imiquimod.
    Santos-Juanes J; Esteve A; Mas-Vidal A; Coto-Segura P; Salgueiro E; Gómez E; Galache Osuna C
    Dermatology; 2011; 222(2):109-12. PubMed ID: 21304243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
    Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
    Berman B; Harrison-Balestra C; Perez OA; Viera M; Villa A; Zell D; Ramirez C
    J Drugs Dermatol; 2009 May; 8(5):455-8. PubMed ID: 19537368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids.
    Chuangsuwanich A; Gunjittisomram S
    J Med Assoc Thai; 2007 Jul; 90(7):1363-7. PubMed ID: 17710978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features, treatment, and outcome of aural hematomas in horses: 7 cases (2008-2019).
    Boorman S; Boone LH; White A
    J Am Vet Med Assoc; 2021 Mar; 258(6):654-660. PubMed ID: 33683965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of imiquimod indirect antiviral activity].
    Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
    Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.
    Theos AU; Cummins R; Silverberg NB; Paller AS
    Cutis; 2004 Aug; 74(2):134-8, 141-2. PubMed ID: 15379366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study.
    Pope E; Doria AS; Theriault M; Mohanta A; Laxer RM
    Dermatology; 2011; 223(4):363-9. PubMed ID: 22327486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.